Delivery Order SPE2DB22D2006-SPE2DB24FW0RG
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,801.63 firm fixed-price delivery order is for the supply of NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,599.42, is for the delivery of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement. The contract has an ultimate completion date of November 20, 2023 and was awarded on November 17, 2023. This award...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,627.60 and is for the delivery of the drug NAROPIN 0.5% 100 MG/20 ML VIAL 20ML. The contract is a firm-fixed price, delivery order type and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, identified as SPE2DB22D3011/SPE2DB24FQ2NC, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,205.49 firm fixed-price delivery order is for the supply of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product. This contract is not set aside for a specific business type. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,013.55 for Naropin 0.5% (150 mg/30 mL vial) with an ultimate completion date of October 16, 2025. This firm fixed price, non-set-aside contract was competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,643.37 delivery order is for the supply of the pharmaceutical product Naropin 0.5% 150 mg/30 ml vial. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naropin 0.5% 150 mg/30 mL vials with a ceiling value of $1,208.93 and an ultimate completion date of December 30, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside procurement. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.5% (150 mg/30 ml) on November 7, 2025, with a ceiling value of $3,164.35 and ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $1,241.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL, 200 mL unit). This competitive award, which carries an ultimate completion date of December 31, 2025, represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's distribution facility in...
- The Defense Logistics Agency awarded a $4,400.42 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL), a local anesthetic pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FW0RGDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $1,899.09 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564717803 - NAROPIN 0.5% 150 MG/30 ML VIAL 30ML. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities worldwide in support of the U.S. Armed Forces. The contract does not have a set-aside designation. Amerisourcebergen, as a major pharmaceutical distribution company, leverages its extensive supply chain network to fulfill these types of federal medical supply contracts for government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 5/25/24 |